This is a preview of subscription content, log in via an institution to check access.
REFERENCE
Ito K, Blinder VS, Elkin EB.Cost-effectiveness of fracture prevention in postmenopausal women receiving aromatase inhibitors for early breast cancer. 2009 Breast Cancer Symposium: abstr. 166, 08 Oct 2009. Available from: URL: http://www.asco.org
Rights and permissions
About this article
Cite this article
Risedronic-acid: more cost effective with wider application. Pharmacoecon. Outcomes News 591, 12 (2009). https://doi.org/10.2165/00151234-200905910-00030
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200905910-00030